Annual Total Debt:
$34.03B-$2.07B(-5.74%)Summary
- As of today (September 17, 2025), TAK annual total debt is $34.03 billion, with the most recent change of -$2.07 billion (-5.74%) on March 1, 2025.
- During the last 3 years, TAK annual total debt has fallen by -$5.61 billion (-14.14%).
- TAK annual total debt is now -36.49% below its all-time high of $53.58 billion, reached on March 31, 2019.
Performance
TAK Total debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly Total Debt:
$31.19B-$2.83B(-8.33%)Summary
- As of today (September 17, 2025), TAK quarterly total debt is $31.19 billion, with the most recent change of -$2.83 billion (-8.33%) on June 1, 2025.
- Over the past year, TAK quarterly total debt has dropped by -$2.88 billion (-8.45%).
- TAK quarterly total debt is now -41.78% below its all-time high of $53.58 billion, reached on March 31, 2019.
Performance
TAK Quarterly Total Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Total debt Formula
Total Debt = Short Term Debt + Long Term Debt
TAK Total debt Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -5.7% | -8.4% |
| 3 y3 years | -14.1% | -7.9% |
| 5 y5 years | -32.8% | -33.7% |
TAK Total debt Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -14.1% | at low | -14.6% | +1.3% |
| 5 y | 5-year | -32.8% | at low | -33.7% | +1.3% |
| alltime | all time | -36.5% | >+9999.0% | -41.8% | >+9999.0% |
TAK Total debt History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $31.19B(-8.3%) |
| Mar 2025 | $34.03B(-5.7%) | $34.03B(+10.5%) |
| Dec 2024 | - | $30.80B(-12.8%) |
| Sep 2024 | - | $35.31B(+3.6%) |
| Jun 2024 | - | $34.07B(-5.6%) |
| Mar 2024 | $36.10B(-1.2%) | $36.10B(+9.1%) |
| Dec 2023 | - | $33.08B(+5.5%) |
| Sep 2023 | - | $31.36B(-4.5%) |
| Jun 2023 | - | $32.84B(-10.1%) |
| Mar 2023 | $36.53B(-7.8%) | $36.53B(+12.4%) |
| Dec 2022 | - | $32.49B(-0.7%) |
| Sep 2022 | - | $32.72B(-3.4%) |
| Jun 2022 | - | $33.88B(-14.5%) |
| Mar 2022 | $39.63B(-13.6%) | $39.63B(+4.8%) |
| Dec 2021 | - | $37.82B(-0.3%) |
| Sep 2021 | - | $37.92B(-4.5%) |
| Jun 2021 | - | $39.70B(-13.5%) |
| Mar 2021 | $45.90B(-9.3%) | $45.90B(-0.3%) |
| Dec 2020 | - | $46.02B(-1.1%) |
| Sep 2020 | - | $46.51B(-1.1%) |
| Jun 2020 | - | $47.04B(-7.0%) |
| Mar 2020 | $50.60B(-5.6%) | $50.60B(+5.3%) |
| Dec 2019 | - | $48.05B(+3.3%) |
| Sep 2019 | - | $46.49B(-11.4%) |
| Jun 2019 | - | $52.47B(-2.1%) |
| Mar 2019 | $53.58B(+448.5%) | $53.58B(+130.6%) |
| Dec 2018 | - | $23.23B(+163.7%) |
| Sep 2018 | - | $8.81B(-1.9%) |
| Jun 2018 | - | $8.98B(-8.0%) |
| Mar 2018 | $9.77B(-9.6%) | $9.77B(-3.3%) |
| Dec 2017 | - | $10.11B(+0.0%) |
| Sep 2017 | - | $10.10B(-0.8%) |
| Jun 2017 | - | $10.19B(-5.7%) |
| Mar 2017 | $10.80B(+47.7%) | $10.80B(+29.1%) |
| Dec 2016 | - | $8.37B(-10.9%) |
| Sep 2016 | - | $9.39B(+1.0%) |
| Jun 2016 | - | $9.30B(+27.2%) |
| Mar 2016 | $7.32B(+17.2%) | $7.32B(+20.5%) |
| Dec 2015 | - | $6.07B(-0.3%) |
| Sep 2015 | - | $6.09B(+1.6%) |
| Jun 2015 | - | $5.99B(-4.0%) |
| Mar 2015 | $6.24B(-26.7%) | $6.24B(-18.0%) |
| Dec 2014 | - | $7.61B(-5.1%) |
| Sep 2014 | - | $8.02B(-15.6%) |
| Jun 2014 | - | $9.51B(+45.7%) |
| Mar 2014 | $8.52B(+32.9%) | $6.52B(-13.4%) |
| Dec 2013 | - | $7.53B(-6.6%) |
| Sep 2013 | - | $8.07B(+47.9%) |
| Jun 2013 | - | $5.45B(-8.5%) |
| Mar 2013 | $6.41B | $5.96B(-4.9%) |
| Dec 2012 | - | $6.27B(-10.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2012 | - | $6.96B(+2.4%) |
| Jun 2012 | - | $6.80B(-0.3%) |
| Mar 2012 | $6.82B(+2732.0%) | $6.82B(-3.0%) |
| Dec 2011 | - | $7.03B(-5.1%) |
| Sep 2011 | - | $7.41B(>+9900.0%) |
| Jun 2011 | - | $15.73M(-93.5%) |
| Mar 2011 | $240.94M(+7.0%) | $240.94M(+510.5%) |
| Dec 2010 | - | $39.47M(+10.2%) |
| Sep 2010 | - | $35.81M(+3.6%) |
| Jun 2010 | - | $34.56M(-84.7%) |
| Mar 2010 | $225.16M(-4.2%) | $225.16M(+542.0%) |
| Dec 2009 | - | $35.07M(+1.3%) |
| Sep 2009 | - | $34.63M(-1.5%) |
| Jun 2009 | - | $35.17M(+8.1%) |
| Mar 2009 | $235.02M(+407.3%) | $32.54M(-20.3%) |
| Dec 2008 | - | $40.81M(+48.9%) |
| Sep 2008 | - | $27.41M(-31.6%) |
| Jun 2008 | - | $40.05M(+18.6%) |
| Mar 2008 | $46.33M(-22.0%) | - |
| Mar 2008 | - | $33.77M(>+9900.0%) |
| Dec 2007 | - | $0.00(-100.0%) |
| Sep 2007 | - | $42.97M(>+9900.0%) |
| Jun 2007 | - | $0.00(-100.0%) |
| Mar 2007 | $59.38M(-21.4%) | - |
| Mar 2007 | - | $42.02M(>+9900.0%) |
| Dec 2006 | - | $0.00(-100.0%) |
| Sep 2006 | - | $43.97M(>+9900.0%) |
| Jun 2006 | - | $0.00(-100.0%) |
| Mar 2006 | $75.59M(-41.7%) | - |
| Mar 2006 | - | $46.16M(>+9900.0%) |
| Dec 2005 | - | $0.00(-100.0%) |
| Sep 2005 | - | $64.83M(>+9900.0%) |
| Jun 2005 | - | $0.00(-100.0%) |
| Mar 2005 | $129.60M(+16.2%) | - |
| Mar 2005 | - | $77.61M(>+9900.0%) |
| Dec 2004 | - | $0.00(-100.0%) |
| Sep 2004 | - | $67.33M(>+9900.0%) |
| Jun 2004 | - | $0.00 |
| Mar 2004 | $111.49M(+38.2%) | - |
| Mar 2003 | $80.70M(-10.4%) | - |
| Mar 2002 | $90.07M(-26.2%) | - |
| Mar 2001 | $122.06M(-45.3%) | - |
| Mar 2000 | $223.10M(+26.8%) | - |
| Mar 1999 | $175.91M(-47.1%) | - |
| Mar 1998 | $332.79M(-24.6%) | - |
| Mar 1997 | $441.62M(-15.9%) | - |
| Mar 1996 | $525.07M(-22.6%) | - |
| Mar 1995 | $678.34M(+47.5%) | - |
| Mar 1994 | $459.98M(-18.1%) | - |
| Mar 1993 | $561.66M(+19.3%) | - |
| Mar 1992 | $470.77M(+21.6%) | - |
| Mar 1991 | $387.24M | - |
FAQ
- What is Takeda Pharmaceutical Company Limited annual total debt?
- What is the all time high annual total debt for Takeda Pharmaceutical Company Limited?
- What is Takeda Pharmaceutical Company Limited annual total debt year-on-year change?
- What is Takeda Pharmaceutical Company Limited quarterly total debt?
- What is the all time high quarterly total debt for Takeda Pharmaceutical Company Limited?
- What is Takeda Pharmaceutical Company Limited quarterly total debt year-on-year change?
What is Takeda Pharmaceutical Company Limited annual total debt?
The current annual total debt of TAK is $34.03B
What is the all time high annual total debt for Takeda Pharmaceutical Company Limited?
Takeda Pharmaceutical Company Limited all-time high annual total debt is $53.58B
What is Takeda Pharmaceutical Company Limited annual total debt year-on-year change?
Over the past year, TAK annual total debt has changed by -$2.07B (-5.74%)
What is Takeda Pharmaceutical Company Limited quarterly total debt?
The current quarterly total debt of TAK is $31.19B
What is the all time high quarterly total debt for Takeda Pharmaceutical Company Limited?
Takeda Pharmaceutical Company Limited all-time high quarterly total debt is $53.58B
What is Takeda Pharmaceutical Company Limited quarterly total debt year-on-year change?
Over the past year, TAK quarterly total debt has changed by -$2.88B (-8.45%)